Exercise Intervention to maintain endurance and mobility in patients undergoing allogenic hematopoetic stem cell transplantation (alloHCT)

Not Applicable

• Conditions: C81-C96; D46; Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue; Myelodysplastic syndromes

• Registration Number: DRKS00005488
• Lead Sponsor: niversitätsklinik Freiburg, Zentrale Einrichtung, Bewegungsmedizin und Sport

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02-04
• Study Completion: 2014-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

All patients eligible for alloHCT
- Signed informed consent

Exclusion Criteria

- instable bone metastases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Endurance capacity, lactate diagnistics and spiroergometry (individaul anaerobic threshold, respiratory thresholds, watt) (Ergoline 900, Jaeger, Hoechberg, Germany)

Secondary Outcome Measures

Name	Time	Method
- mobility [sway path (cm), chair rising test(s)]; <br>- hand grip strength (kg); <br>- body composition [phase angle (°), fat mass, fat-free mass (%), body cell mass(kg)]; <br>- questionnaire (quality of life EORTC QLQ-C30, side effects)